Serum glial fibrillary acidic protein (GFAP)-antibody in idiopathic intracranial hypertension

Idiopathic intracranial hypertension (IIH), a disease of obscure origin, is characterized by headache and visual disturbances due to increased intracranial pressure. Recent line of evidence has suggested involvement of inflammation in IIH pathogenesis thus bringing forward anti-glial autoimmunity as...

Full description

Saved in:
Bibliographic Details
Published in:International journal of neuroscience 2021-08, Vol.131 (8), p.775-779
Main Authors: Yetimler, Berrak, Tzartos, John, Şengül, Büşra, Dursun, Erdinç, Ulukan, Çağrı, Karagiorgou, Katerina, Gezen-Ak, Duygu, Sezgin, Mine, Papaconstantinou, Aliki, Tzartos, Socrates, Orhan, Elif Kocasoy, Ekizoğlu, Esme, Küçükali, Cem İsmail, Baykan, Betül, Tüzün, Erdem
Format: Article
Language:English
Subjects:
Adult
antibody
Autoantibodies - blood
autoimmunity
Female
glial fibrillary acidic protein
Glial Fibrillary Acidic Protein - blood
Glial Fibrillary Acidic Protein - immunology
headache
Humans
Idiopathic intracranial hypertension
Male
Pseudotumor Cerebri - blood
Pseudotumor Cerebri - cerebrospinal fluid
Pseudotumor Cerebri - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Idiopathic intracranial hypertension (IIH), a disease of obscure origin, is characterized by headache and visual disturbances due to increased intracranial pressure. Recent line of evidence has suggested involvement of inflammation in IIH pathogenesis thus bringing forward anti-glial autoimmunity as a potential contributor of IIH. Glial fibrillary acidic protein (GFAP) is a major astrocytic autoantigen associated with a specific form of meningoencephalitis. In this study, we investigated the presence of GFAP-antibody in 65 sera (49 obtained during active disease and 16 during remission) and in 15 cerebrospinal fluid (CSF) samples of 58 consecutively recruited IIH patients using cell based assay and indirect immunohistochemistry. GFAP-antibody was found in active period sera of 2 IIH patients with classical symptoms and good treatment response. Two remission period sera obtained at different time points from one of these cases showed lower titers of GFAP-antibody positivity. IgG from positive samples yielded an astrocytic immunoreactivity pattern. None of the CSF samples showed GFAP-antibodies. These results suggest that anti-astrocyte autoimmunity might be present in a fraction of IIH patients. Exact pathogenic significance of this association needs to be further studied.
ISSN:0020-7454
1563-5279
1543-5245
DOI:10.1080/00207454.2020.1758084